Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | AB INBEV | 5 | 30 | +0,42 % | |
| UMICORE | 1 | 2 | +0,23 % | |
| UCB | 1 | - | +0,12 % | |
| ARGENX | - | 10 | +0,21 % | ||
| MELEXIS | - | 4 | 0,00 % | |
| ELIA GROUP | - | 4 | -0,07 % | |
| AGEAS | - | 1 | -0,07 % | |
| KBC GROEP NV | - | 1 | -0,09 % | |
| GBL | - | 1 | -0,44 % | |
| MONTEA | - | 1 | +0,98 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Anheuser-Busch doubles US manufacturing investment to $600M | 4 | Food Dive | ||
| Mi | Budweiser Maker Anheuser-Busch Unleashes $600 Million US Manufacturing Push | 2 | Benzinga.com | ||
| Mi | Umicore - Transparency notification by Bank of America Corporation | 6 | GlobeNewswire (USA) | ||
| Mi | Budweiser-maker Anheuser-Busch lays out $600 million investment plan for US facilities | 2 | Reuters | ||
| Mi | Anheuser-Busch invests in U.S. manufacturing as it retains its strong market share lead | 6 | Seeking Alpha | ||
| Mi | Anheuser-Busch raises U.S. manufacturing investment to $600 million | 3 | Investing.com | ||
| Mi | UCB: $1.15 Billion Neurona Therapeutics Acquisition To Advance Epilepsy Treatments | 4 | pulse2.com | ||
| Di | Solvay S.A.: Participation notification by Citigroup Inc. | 494 | GlobeNewswire (Europe) | Press release Regulated information
Brussels, April 21, 2026, 17:45 CEST
In line with Belgian transparency legislation (Law... ► Artikel lesen | |
| Di | UCB partners with Myasthenia Gravis Foundation of America on meal program targeting nutrition deserts | 1 | FiercePharma | ||
| Di | ANHEUSER-BUSCH INBEV SA/NV: Ruhe vor der nächsten Bewegung | 8 | Maximilian Berger | ||
| Di | Why BlackRock's investment in Anheuser-Busch InBev didn't shake the market | 20 | IOL | ||
| Mo | GBL: GBL - Transactions on GBL shares 20-04-2026 | 1 | Euronext | ||
| Mo | Interview with Laurein Cornelissen, Team Lead Expertise Power Transformers at Elia | 3 | Transformers | ||
| Mo | BERNSTEIN RESEARCH stuft AB Inbev auf 'Outperform' | 641 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für AB Inbev von 83 auf 87 Euro angehoben und die Einstufung auf "Outperform" belassen. Trevor Stirling zog in einer... ► Artikel lesen | |
| Mo | UCB Proposes $650M Acquisition of Neurona Therapeutics | 5 | Contract Pharma | ||
| Mo | UCB to purchase Neurona and NRTX-1001 for $1.15bn | 1 | Pharmaceutical Technology | ||
| Mo | UCB cuts $1.15bn deal to buy epilepsy biotech Neurona | 4 | pharmaphorum | ||
| Mo | ARGENX SE - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mo | Italy's private equity weekly roundup. News from BeBeez, Di Luccia & Partners, Banca Investis, Duke&Kay, Recordati, CVC, Groupe Bruxelles Lambert, Adia, Gic, Caisse de Depot et Placement du Quebec, and more | 5 | BeBeez | ||
| Mo | KBC Groep: Notification for bondholders of KBC IFIMA | 250 | GlobeNewswire (Europe) | Following document is available on www.kbc.com:
- 2025 financial report of KBC IFIMA
► Artikel lesen |
1 2 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.